Pharma · Gene-to-GMP CMC
Synthesis
A platform that drafts the chemistry, manufacturing, and controls proposal that takes a therapy from gene to GMP. The data could not leave the customer's control, and the cost could not float, so we pushed the whole thing onto a self-hosted open model. We decomposed it into a grounded pipeline — a 49-document regulatory RAG corpus, 13 concurrent work-packages, deterministic validators — and a QLoRA fine-tune brought a local OLMo-3.1-32B level with a leading frontier model on the hardest regulatory-judgment panel. Every cited source checked out. On-prem, customer-controlled, roughly $16 a month to keep the model parked.
- Self-hosted OLMo-3.1-32B
- 49-doc regulatory RAG
- QLoRA fine-tune
- Frontier-level on the hard panel
- ~$16/mo parked







